Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hy-drogel formulations

Details for Australian Patent Application No. 2012216443 (hide)

Owner The General Hospital Corporation DBA Massachusetts General Hospital

Inventors Muratoglu, Orhun K.; Oral, Ebru; Bodugoz-Senturk, Hatice

Agent Fisher Adams Kelly

Pub. Number AU-A-2012216443

Parent 2007267550

Filing date 27 August 2012

Wipo publication date 13 September 2012

International Classifications

B01D 21/01 Separation of suspended solid particles from liquids by sedimentation - using flocculating agents

A61F 13/00 Bandages, dressings or absorbent pads

A61K 9/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

B01D 43/00 Separating particles from liquids, or liquids from solids, otherwise than by sedimentation or filtration

B01F 3/00 Mixing, e.g. dispersing, emulsifying, according to the phases to be mixed

B01F 17/00 Use of substances as emulsifying, wetting, dispersing, or foam-producing agents

B01J 13/00 Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for

C09K 3/00 Materials not provided for elsewhere

Event Publications

6 September 2012 Complete Application Filed

13 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216443

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216444-Sound dampening conveyor chain flight

2012216442-A leak resistant pack for a solid or liquid product